Income Statement Seelos Therapeutics, Inc.

Stocks

SEELQ

US81577F4063

Biotechnology & Medical Research

Delayed OTC Markets 02:25:32 02/06/26 am AEST			5-day change	1st Jan Change
0.000100 ^USD	+9,900.00%		-.--%	+9,900.00%

29/12	Motion for Asset Sale Approved for Seelos Therapeutics, Inc.	CI
22/10/25	GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q).	CI

8ed294d3a68dc2500542.s6dC1ZO2mwXxuuNiB1pvNVm1aXYVqN_7WkJhr7LitQI.g_0S4snFq1PCyNcaMz0BRmmHMDBQ5ZGsLnMbnsXV8VSB-BaMxo_KM7bShA

Published financial data: SEELOS THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	375K	-	-	-	2.2M
Total Revenues	375K	-	-	-	2.2M
Cost of Goods Sold, Total	-	10.98M	-	-	30.12M
Gross Profit	375K	-10.98M	-	-	-27.91M
Selling General & Admin Expenses, Total	5.56M	7.78M	15.02M	12.3M	12.58M
R&D Expenses	22.56M	-	46.65M	58.62M	-
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	28.12M	7.78M	61.67M	70.92M	12.58M
Operating Income	-27.75M	-18.76M	-61.67M	-70.92M	-40.5M
Interest Expense, Total	-29K	-164K	-1.6M	-14K	-75K
Interest And Investment Income	151K	45K	113K	121K	198K
Net Interest Expenses	122K	-119K	-1.48M	107K	123K
Other Non Operating Income (Expenses)	-21.52M	-223K	-886K	292K	13.69M
EBT, Excl. Unusual Items	-49.15M	-19.1M	-64.04M	-70.52M	-26.68M
Merger & Related Restructuring Charges	-2M	-	-	-	-
Other Unusual Items	-109K	-	-2.01M	-3.02M	-11.2M
EBT, Incl. Unusual Items	-51.26M	-19.1M	-66.05M	-73.53M	-37.88M
Earnings From Continuing Operations	-51.26M	-19.1M	-66.05M	-73.53M	-37.88M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-51.26M	-19.1M	-66.05M	-73.53M	-37.88M
Net Income - (IS)	-51.26M	-19.1M	-66.05M	-73.53M	-37.88M
Net Income to Common Incl Extra Items	-51.26M	-19.1M	-66.05M	-73.53M	-37.88M
Net Income to Common Excl. Extra Items	-51.26M	-19.1M	-66.05M	-73.53M	-37.88M
Per Share Items
Net EPS - Basic	-	-1.64K	-2.79K	-2.66K	-989.53
Basic EPS - Continuing Operations	-	-1.64K	-2.79K	-2.66K	-989.53
Basic Weighted Average Shares Outstanding	-	11.66K	23.67K	27.69K	38.28K
Net EPS - Diluted	-	-1.64K	-2.79K	-2.66K	-989.53
Diluted EPS - Continuing Operations	-	-1.64K	-2.79K	-2.66K	-989.53
Diluted Weighted Average Shares Outstanding	-	11.66K	23.67K	27.69K	38.28K
Normalized Basic EPS	-	-1.02K	-1.69K	-1.59K	-435.6
Normalized Diluted EPS	-	-1.02K	-1.69K	-1.59K	-435.6
Supplemental Items
EBITDA	-27.71M	-	-	-	-
EBITA	-27.75M	-18.76M	-61.67M	-70.92M	-40.5M
EBIT	-27.75M	-18.76M	-61.67M	-70.92M	-40.5M
EBITDAR	-27.61M	-	-	-	-
Total Revenues (As Reported)	375K	-	-	-	2.2M
Normalized Net Income	-30.72M	-11.94M	-40.02M	-44.07M	-16.68M
Interest on Long-Term Debt	-	-	1.6M	14K	75K
Supplemental Operating Expense Items
General and Administrative Expenses	5.56M	7.78M	15.02M	12.3M	12.58M
Research And Development Expense From Footnotes	22.56M	10.98M	46.65M	58.62M	30.12M
Net Rental Expense, Total	100K	100K	100K	100K	100K
Imputed Operating Lease Interest Expense	-	-	89.14K	573	3.49K
Imputed Operating Lease Depreciation	-	-	10.86K	99.43K	96.51K
Stock-Based Comp., COGS (Total)	-	394K	717K	-	1.04M
Stock-Based Comp., R&D Exp. (Total)	118K	-	-	932K	-
Stock-Based Comp., G&A Exp. (Total)	341K	1.65M	7.63M	4.14M	2.95M
Stock-Based Comp., Other (Total)	-	124K	-	-	-
Total Stock-Based Compensation	459K	2.17M	8.35M	5.07M	3.99M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	10.26M	15.66M	78.73M	15.53M	3M
Total Cash And Short Term Investments	10.26M	15.66M	78.73M	15.53M	3M
Accounts Receivable, Total	-	-	-	-	763K
Total Receivables	-	-	-	-	763K
Prepaid Expenses	835K	1.83M	4.54M	6.94M	1.57M
Other Current Assets, Total	-	-	187K	200K	77K
Total Current Assets	11.1M	17.49M	83.46M	22.67M	5.4M
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	-	-	39K	72K	15K
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	11.1M	17.49M	83.5M	22.75M	5.42M
Liabilities
Accounts Payable, Total	796K	1.89M	1.69M	3.63M	16.4M
Accrued Expenses, Total	1.92M	1.92M	3.73M	7.28M	2.52M
Current Portion of Long-Term Debt	-	2.43M	1.03M	11.86M	14.21M
Current Portion of Leases	-	-	38K	58K	15K
Other Current Liabilities	8.06M	1.19M	1.8M	2.33M	5.78M
Total Current Liabilities	10.78M	7.43M	8.29M	25.16M	38.93M
Long-Term Debt	-	7.29M	17.89M	8.18M	-
Long-Term Leases	-	-	-	15K	-
Other Non Current Liabilities	325K	200K	-	-	-
Total Liabilities	11.1M	14.92M	26.18M	33.36M	38.93M
Common Stock, Total	27K	54K	105K	107K	10K
Additional Paid In Capital	56.03M	77.68M	198M	204M	219M
Retained Earnings	-56.06M	-75.16M	-141M	-215M	-253M
Total Common Equity	-7K	2.57M	57.32M	-10.61M	-33.51M
Total Equity	-7K	2.57M	57.32M	-10.61M	-33.51M
Total Liabilities And Equity	11.1M	17.49M	83.5M	22.75M	5.42M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	9.51K	19.08K	27.48K	28.15K	107K
ECS Total Common Shares Outstanding	7.04K	14.2K	27.47K	27.91K	76.52K
Book Value / Share	-0.99	181.1	2.09K	-380.21	-437.92
Tangible Book Value	-7K	2.57M	57.32M	-10.61M	-33.51M
Tangible Book Value Per Share	-0.99	181.1	2.09K	-380.21	-437.92
Total Debt	0	9.72M	18.96M	20.12M	14.23M
Net Debt	-10.26M	-5.94M	-59.78M	4.59M	11.23M
Debt Equivalent Oper. Leases	800K	800K	800K	800K	800K
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	-	-	-	-	-
Full Time Employees	6	9	15	15	15
Part Time Employees	-	1	1	1	1
Assets under Capital Lease - Gross	-	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-51.26M	-19.1M	-66.05M	-73.53M	-37.88M
Depreciation & Amortization - CF	-	-	-	53K	57K
Depreciation & Amortization, Total	-	-	-	53K	57K
Amortization of Deferred Charges, Total - (CF)	-	150K	1.58M	-	-
Asset Writedown & Restructuring Costs	3M	192K	5.64M	1.3M	-
Stock-Based Compensation (CF)	459K	2.17M	8.35M	5.07M	3.99M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	21.63M	223K	2.89M	2.72M	-2.49M
Change In Accounts Payable	-1.42M	1.09M	-194K	1.93M	12.78M
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	8.28M	-5.64M	-1.21M	850K	-358K
Cash from Operations	-19.3M	-20.91M	-49M	-61.6M	-23.91M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Cash from Investing	-	-	-	-	-
Long-Term Debt Issued, Total	-	147K	-	-	-
Total Debt Issued	-	147K	-	-	-
Long-Term Debt Repaid, Total	-	-	-13.55M	-1.89M	-7.64M
Total Debt Repaid	-	-	-13.55M	-1.89M	-7.64M
Issuance of Common Stock	13M	26.17M	126M	564K	20.21M
Repurchase of Common Stock	-	-	-	-	-1.2M
Other Financing Activities, Total	16.52M	-	-	-273K	-
Cash from Financing	29.52M	26.31M	112M	-1.6M	11.38M
Net Change in Cash	10.22M	5.4M	63.07M	-63.2M	-12.54M
Supplemental Items
Cash Interest Paid	16K	11K	10K	11K	505K
Levered Free Cash Flow	-9.26M	-16.29M	-30.29M	-35.6M	-5.11M
Unlevered Free Cash Flow	-9.25M	-16.33M	-30.87M	-35.59M	-5.07M
Change In Net Working Capital	-7.64M	6.78M	674K	-3.6M	-16.2M
Net Debt Issued / Repaid	-	147K	-13.55M	-1.89M	-7.64M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-307.29	-82.02	-76.33	-83.43	-179.75
Return on Total Capital	1.53K	-190.81	-87.03	-103.33	518.1
Return On Equity %	2.18K	-1.49K	-220.55	-314.84	171.72
Return on Common Equity	2.18K	-1.49K	-220.55	-314.84	171.72
Margin Analysis
Gross Profit Margin %	100	-	-	-	-1.27K
SG&A Margin	1.48K	-	-	-	571.27
EBITDA Margin %	-7.39K	-	-	-	-
EBITA Margin %	-7.4K	-	-	-	-1.84K
EBIT Margin %	-7.4K	-	-	-	-1.84K
Income From Continuing Operations Margin %	-13.67K	-	-	-	-1.72K
Net Income Margin %	-13.67K	-	-	-	-1.72K
Net Avail. For Common Margin %	-13.67K	-	-	-	-1.72K
Normalized Net Income Margin	-8.19K	-	-	-	-756.98
Levered Free Cash Flow Margin	-2.47K	-	-	-	-232.17
Unlevered Free Cash Flow Margin	-2.47K	-	-	-	-230.04
Asset Turnover
Asset Turnover	0.07	-	-	-	0.16
Fixed Assets Turnover	-	-	-	-	50.64
Short Term Liquidity
Current Ratio	1.03	2.35	10.07	0.9	0.14
Quick Ratio	0.95	2.11	9.5	0.62	0.1
Operating Cash Flow to Current Liabilities	-1.79	-2.82	-5.91	-2.45	-0.61
Average Days Payable Outstanding	-	44.7	-	-	121.37
Long Term Solvency
Total Debt/Equity	-	378.07	33.07	-189.63	-42.46
Total Debt / Total Capital	-	79.08	24.85	211.57	-73.79
LT Debt/Equity	-	283.55	31.21	-77.27	-
Long-Term Debt / Total Capital	-	59.31	23.45	86.21	-
Total Liabilities / Total Assets	100.06	85.3	31.35	146.65	718.49
EBIT / Interest Expense	-956.79	-114.38	-38.59	-5.07K	-539.99
EBITDA / Interest Expense	-955.38	-	-38.53	-5.06K	-538.65
(EBITDA - Capex) / Interest Expense	-955.38	-	-38.53	-5.06K	-538.65
Total Debt / EBITDA	-	-	-0.31	-0.28	-0.35
Net Debt / EBITDA	0.37	-	0.97	-0.06	-0.28
Total Debt / (EBITDA - Capex)	-	-	-0.31	-0.28	-0.35
Net Debt / (EBITDA - Capex)	0.37	-	0.97	-0.06	-0.28
Growth Over Prior Year
Gross Profit, 1 Yr. Growth %	-	-50.5	-	-	-52.38
EBITDA, 1 Yr. Growth %	781.51	-	-	-	-
EBITA, 1 Yr. Growth %	771.45	-32.39	228.74	14.99	-42.89
EBIT, 1 Yr. Growth %	771.45	-32.39	228.74	14.99	-42.89
Earnings From Cont. Operations, 1 Yr. Growth %	1.37K	-62.73	245.78	11.33	-48.48
Net Income, 1 Yr. Growth %	1.37K	-62.73	245.78	11.33	-48.48
Normalized Net Income, 1 Yr. Growth %	1.38K	-61.13	235.27	10.11	-62.16
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	70.31	-4.84	-62.73
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	84.62	-79.17
Total Assets, 1 Yr. Growth %	5.71K	57.66	377.31	-72.76	-76.18
Tangible Book Value, 1 Yr. Growth %	-99.85	-36.84K	2.13K	-118.51	215.8
Common Equity, 1 Yr. Growth %	-99.85	-36.84K	2.13K	-118.51	215.8
Cash From Operations, 1 Yr. Growth %	1.12K	8.33	134.28	25.74	-61.18
Levered Free Cash Flow, 1 Yr. Growth %	778.21	75.8	85.97	17.55	-85.63
Unlevered Free Cash Flow, 1 Yr. Growth %	850.24	76.66	89	15.3	-85.76
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	62.01	-	-	-	-
EBITA, 2 Yr. CAGR %	61.24	142.73	49.08	94.43	-18.96
EBIT, 2 Yr. CAGR %	61.24	142.73	49.08	94.43	-18.96
Earnings From Cont. Operations, 2 Yr. CAGR %	108.87	134.45	13.52	96.21	-24.27
Net Income, 2 Yr. CAGR %	1.16K	134.45	13.52	96.21	-24.27
Normalized Net Income, 2 Yr. CAGR %	108.32	140.04	14.15	92.14	-35.45
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	27.3	-40.45
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-	-	-37.98
Total Assets, 2 Yr. CAGR %	28.63	857.04	174.32	14.03	-74.53
Tangible Book Value, 2 Yr. CAGR %	-96	-26.07	8.95K	103.12	-23.54
Common Equity, 2 Yr. CAGR %	-96	-26.07	8.95K	103.12	-23.54
Cash From Operations, 2 Yr. CAGR %	35.81	263.7	59.31	71.63	-30.14
Levered Free Cash Flow, 2 Yr. CAGR %	-	292.92	80.81	47.86	-58.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	309.71	82.72	47.62	-59.48
Compound Annual Growth Rate Over Three Years
EBITA, 3 Yr. CAGR %	298.9	20.68	168.55	36.72	29.24
EBIT, 3 Yr. CAGR %	298.9	20.68	168.55	36.72	29.24
Earnings From Cont. Operations, 3 Yr. CAGR %	389.45	17.58	166.87	12.78	25.64
Net Income, 3 Yr. CAGR %	389.45	290.41	166.87	12.78	25.64
Normalized Net Income, 3 Yr. CAGR %	382.64	19.03	168.32	12.79	11.79
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-15.47
Total Assets, 3 Yr. CAGR %	-	37.66	658.96	27.03	-32.34
Tangible Book Value, 3 Yr. CAGR %	-69.79	-16.2	130.09	1.05K	135.31
Common Equity, 3 Yr. CAGR %	-69.79	-16.2	130.09	1.05K	135.31
Cash From Operations, 3 Yr. CAGR %	-	25.95	214.1	47.22	4.57
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	206.21	56.64	-32.03
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	216.57	56.73	-32.3
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	-	-	169.08	46.05	66.3
EBIT, 5 Yr. CAGR %	-	-	169.08	46.05	66.3
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	172.8	44.31	61.25
Net Income, 5 Yr. CAGR %	-	-	172.8	196.48	61.25
Normalized Net Income, 5 Yr. CAGR %	-	-	171.12	44.16	51.76
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-1.84	-
Total Assets, 5 Yr. CAGR %	-	-	-	27.67	95.24
Tangible Book Value, 5 Yr. CAGR %	-	-	195.6	19.41	48.08
Common Equity, 5 Yr. CAGR %	-	-	195.6	19.41	48.08
Cash From Operations, 5 Yr. CAGR %	-	-	-	42.55	72.16
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	37.13
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	39.1